A detailed history of Louisiana State Employees Retirement System transactions in Alkermes Plc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 79,600 shares of ALKS stock, worth $2.36 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
79,600
Previous 85,100 6.46%
Holding current value
$2.36 Million
Previous $2.05 Million 8.68%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$23.01 - $28.55 $126,555 - $157,025
-5,500 Reduced 6.46%
79,600 $2.23 Million
Q2 2024

Jul 24, 2024

BUY
$23.21 - $27.24 $58,025 - $68,100
2,500 Added 3.03%
85,100 $2.05 Million
Q1 2024

Apr 23, 2024

SELL
$26.4 - $32.56 $23,760 - $29,304
-900 Reduced 1.08%
82,600 $2.24 Million
Q4 2023

Jan 29, 2024

BUY
$23.37 - $28.68 $1.95 Million - $2.39 Million
83,500 New
83,500 $2.32 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.88B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Louisiana State Employees Retirement System Portfolio

Follow Louisiana State Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.